Alison Betts

Company: Takeda Pharmaceutical

Job title: Global Head of Drug Metabolism & Pharmacokinetics

Seminars:

More Than the Sum of Their Parts: Integrating Data & Knowledge of ADCs in a QSP Platform Model to Predict Efficacy and Toxicity In the Clinic 9:30 am

Implementation of a next generation platform systems pharmacology model for preclinical to clinical translation of ADC efficacy, clinical dose predictions including outcome (RECIST) criteria and differentiation from SoC in different oncology indications Development of a mechanistic model for prediction of ADC induced haematological toxicities and use to predict optimal dose and regimen to avoid thrombocytopeniaRead more

day: Conference Day 1